8-K//Current report
CASI Pharmaceuticals, Inc. 8-K
Accession 0001104659-23-008576
CIK 0000895051operating
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:01 PM ET
Size
328.3 KB
Accession
0001104659-23-008576
Documents
- 8-Ktm234607d1_8k.htmPrimary
FORM 8-K
- EX-2.1tm234607d1_ex2-1.htm
EXHIBIT 2.1
- EX-101.SCHcasi-20230131.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABcasi-20230131_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREcasi-20230131_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLtm234607d1_8k_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001104659-23-008576-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
CASI Pharmaceuticals, Inc (DE)
CIK 0000895051
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000895051
Filing Metadata
- Form type
- 8-K
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 4:01 PM ET
- Size
- 328.3 KB